{{medical}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 419619495
| IUPAC_name = (''RS'')-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one
| image = Lorazepam.svg
| width = 200
| image2 = Lorazepam ball-and-stick model.png
| width2 = 180

<!-- Clinical data-->
| tradename = Ativan and others
| Drugs.com = {{drugs.com|monograph|lorazepam}}
| MedlinePlus = a682053
| pregnancy_AU = C
| pregnancy_US = D
| legal_AU = S4
| legal_CA = Schedule IV
| legal_UK = CD (Benz) POM
| legal_US = Schedule IV
| dependency_liability = 中至高
| routes_of_administration = 口服, 肌肉注射, 靜脈注射, 舌下給藥

<!-- Pharmacokinetic data-->
| bioavailability = 85%
| metabolism = [[Liver|Liver]] [[glucuronidation|glucuronidation]]
| elimination_half-life = 10–20 小時<ref>{{Cite journal | author = Greenblatt DJ, Shader RI, Franke K, Maclaughlin DS, Harmatz JS, Allen MD, Werner A, Woo E | title = Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans | journal = Journal of Pharmaceutical Sciences | year = 1991 | volume = 68 | issue = 1 | pages = 57–63 | pmid = 31453 | doi = 10.1002/jps.2600680119 }}</ref><ref>{{Cite journal | author = Greenblatt DJ, von Moltke LL, Ehrenberg BL, Harmatz JS, Corbett KE, Wallace DW, Shader RI | title = Kinetics and dynamics of lorazepam during and after continuous intravenous infusion | journal = Critical Care Medicine | volume = 28 | issue = 8 | pages = 2750–2757 | year = 2000 | pmid = 10966246 | doi = 10.1097/00003246-200008000-00011}}</ref><ref name="kineticracemization">{{Cite journal | author = Papini O, da Cunha SP, da Silva Mathes Ado C, Bertucci C, Moisés EC, de Barros Duarte L, de Carvalho Cavalli R, Lanchote VL | title = Kinetic disposition of lorazepam with a focus on the glucuronidation capacity, transplacental transfer in parturients and racemization in biological samples | journal = Journal of Pharmaceutical and Biomedical Analysis | year = 2006 | volume = 40 | issue = 2 | pages = 397–403 | pmid = 16143486 | doi = 10.1016/j.jpba.2005.07.021}}</ref>
| excretion = [[腎臟|腎臟]]

<!-- Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 846-49-1
| ATC_prefix = N05
| ATC_suffix = BA06
| PubChem = 3958
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00186
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3821
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = O26FZP769L
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00365
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 580

<!-- Chemical data-->
| C=15 | H=10 | Cl=2 | N=2 | O=2
| molecular_weight = 321.2 g/mol
| smiles = ClC1=CC=CC=C1C2=NC(C(NC3=C2C=C(C=C3)Cl)=O)O
| InChI = 1/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DIWRORZWFLOCLC-UHFFFAOYSA-N
| synonyms = O-Chloroxazepam, L-Lorazepam Acetate
}}

<!-- 定義及用途 -->
'''劳拉西泮'''（'''Lorazepam'''），商品名'''罗拉'''、'''安定文錠'''或'''阿提凡'''（Ativan）<ref>{{cite news |url=http://tw.news.yahoo.com/%E6%89%81%E8%BE%A6-%E5%90%83%E7%B2%BE%E7%A5%9E%E7%A7%91%E7%94%A8%E8%97%A5%E9%81%9414%E5%80%8B%E6%9C%88-%E6%89%81%E4%B8%8D%E7%9F%A5%E6%83%85-071328457.html |title=扁辦：吃精神科用藥達14個月 扁不知情| language=zh-hant |date=2012-03-10 |accessdate=2012-03-10}}</ref>是[[苯二氮䓬类|苯二氮䓬类]]（BZD）藥物<ref name=AHSP2016/>。可用來治療[[焦虑症|焦虑症]]、[[失眠|失眠]]、包括[[癲癇重積狀態|癲癇重積狀態]]在內的積極[[癲癇發作|癲癇發作]]、[[酒精戒斷症候群|酒精戒斷症候群]]、{{le|化療引起的噁心和嘔吐|Chemotherapy-induced nausea and vomiting}}，也用在手術中的[[顺行性遗忘症|保護性失憶]]，以及{{le|機械式呼吸輔助|Mechanical ventilation}}患者的[[鎮靜劑|鎮靜劑]]<ref name=AHSP2016>{{cite web|title=Lorazepam|url=https://www.drugs.com/monograph/lorazepam.html|website=drugs.com|publisher=American Society of Health-System Pharmacists|accessdate=15 July 2016|date=June 29, 2016|deadurl=no|archiveurl=https://web.archive.org/web/20160605073500/http://www.drugs.com/monograph/lorazepam.html|archivedate=5 June 2016}}</ref><ref>{{cite web|title=Lorazepam: MedlinePlus Drug Information|url=https://medlineplus.gov/druginfo/meds/a682053.html#why|website=medlineplus.gov|accessdate=16 July 2016|date=1 October 2010|deadurl=no|archiveurl=https://web.archive.org/web/20160819014154/https://medlineplus.gov/druginfo/meds/a682053.html#why|archivedate=19 August 2016}}</ref>。勞拉西泮可用在{{le|精神運激動|Psychomotor agitation}}，但此情形下較常使用[[咪達唑侖|咪達唑侖]]<ref name=AHSP2016/>，勞拉西泮也用在因使用[[可卡因|可卡因]]造成的[[急性冠状动脉综合症|急性冠状动脉综合症]]治療<ref name=AHSP2016/>。勞拉西泮可以口服，也可以注射到肌肉或是血管中<ref name=AHSP2016/>，注射後約一至30分鐘內就會有效，效果會持續一整天<ref name=AHSP2016/>。

<!-- 副作用 -->
常見的副作用包含虛弱、昏睡、低血壓、以及呼吸困難<ref name=AHSP2016/>，若是用注射的方式對患者給藥，給藥後需密集監控<ref name=AHSP2016/>，若患者有憂鬱的情形，可能會提高其[[自殺|自殺]]的風險<ref name=AHSP2016/><ref name=Doc2017>{{Cite journal|last=Dodds|first=Tyler J.|date=2017-03-02|title=Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature|journal=The primary care companion for CNS disorders|volume=19|issue=2|doi=10.4088/PCC.16r02037|issn=2155-7780|pmid=28257172}}</ref>。長期使用會造成[[藥物耐受性|藥物耐受性]]<ref name=AHSP2016/>，也有可能出現[[身体依赖|生理]]及[[精神依赖|心理依賴]]的情形<ref name=AHSP2016/>。若長期使用後突然停藥，可能會有{{le|苯二氮䓬類戒斷症候群|Benzodiazepine withdrawal syndrome}}<ref name=AHSP2016/>。年長的人更常出現不利影響<ref name="Riss-2008">{{Cite journal |vauthors=Riss J, Cloyd J, Gates J, Collins S | title = Benzodiazepines in epilepsy: pharmacology and pharmacokinetics | journal = Acta Neurologica Scandinavica | volume = 118 | issue = 2 | pages = 69–86 | year = 2008 | doi = 10.1111/j.1600-0404.2008.01004.x | pmid = 18384456 }}</ref>，比較容易跌倒而造成{{le|髖部骨折|Hip fracture}}<ref name="Mets-2010">{{Cite journal |vauthors=Mets MA, Volkerts ER, Olivier B, Verster JC | title = Effect of hypnotic drugs on body balance and standing steadiness | journal = Sleep Medicine Reviews | year = 2010 | volume = 14 | issue = 4 | pages = 259–267 | doi = 10.1016/j.smrv.2009.10.008 | pmid = 20171127 }}</ref>，因為上述原因，一般劳拉西泮給藥最多只會給二到四週<ref name=Altrx2007>{{cite web |url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017794s034s035lbl.pdf |title=Ativan (lorazepam) Tablets Rx only |date=March 2007 |publisher=[[Food_and_Drug_Administration|Food and Drug Administration]] |format=PDF |quote=In general, benzodiazepines should be prescribed for short periods only (e.g. 2–4 weeks). Extension of the treatment period should not take place without reevaluation of the need for continued therapy. Continuous long-term use of product is not recommended. |deadurl=no |archiveurl=https://web.archive.org/web/20110917064143/http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017794s034s035lbl.pdf |archivedate=2011-09-17 }}</ref>。

<!-- 歷史、社會及文化 -->
勞拉西泮於1963年獲得專利，並於1977年開始於美國銷售<ref>{{cite book|last1=Shorter|first1=Edward|title=A Historical Dictionary of Psychiatry|date=2005|publisher=Oxford University Press|isbn=978-0-19-029201-0|url=https://books.google.com/books?id=juAJCAAAQBAJ&pg=PT66|chapter=B|deadurl=no|archiveurl=https://web.archive.org/web/20170328043221/https://books.google.com/books?id=juAJCAAAQBAJ&pg=PT66|archivedate=2017-03-28}}</ref>。本品列名於[[世界衛生組織標準藥物清單|世界衛生組織標準藥物清單]]之中，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016}}</ref>，本品屬於學名藥<ref name=AHSP2016/>。2014年，每錠口服藥錠在開發中國家的批發價介於0.02至0.16美金之間<ref>{{cite web|title=Lorazepam |url=http://mshpriceguide.org/en/single-drug-information/?DMFId=483&searchYear=2014 |website=International Drug Price Indicator Guide|accessdate=16 July 2016}}</ref>。在2015年的美國，劑量的口服劑型每月需25美金<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=437}}</ref>。在2011年的美國，本品為用量第二大宗的苯二氮䓬类藥物，僅次於[[阿普唑侖|阿普唑侖]]，每年處方數量達2800萬筆<ref>{{cite web|title=Benzodiazepines (Street Names: Benzos, Downers, Nerve Pills, Tranks)|url=http://www.deadiversion.usdoj.gov/drug_chem_info/benzo.pdf|accessdate=16 July 2016|date=Jan 2013|deadurl=no|archiveurl=https://web.archive.org/web/20160611075806/http://www.deadiversion.usdoj.gov/drug_chem_info/benzo.pdf|archivedate=11 June 2016}}</ref>。

[[File:Lora_sales_in_China.jpg|thumb]]

==适应症==
主要用于[[焦虑症|焦虑症]]的'''短期'''治疗，但因生活[[压力|压力]]导致的[[焦虑|焦虑]]或[[紧张|紧张]]通常不需要使用本药物治疗。
==药物过量==
劳拉西泮的过量应用主要发生在与酒精和／或其他药物联合用药的情况。
轻度过量症状包括嗜睡，思维混乱和自相矛盾的反应、构音障碍和昏睡。
更严重的症状特别是与其他的药品或酒精同时服用时，症状可能包含运动失调，张力减退，低血压，心血管系统抑制、呼吸抑制、催眠状态，1-3度昏迷和死亡。

过量时可服用[[活性炭|活性炭]]，以减少对药物的吸收。在没有抽吸危险时，可以给予[[洗胃|洗胃]]。

==注意事项==
#包括劳拉西泮在内的[[苯二氮卓类药物|苯二氮卓类药物]]不论是单独应用或与其它中枢抑制剂联合应用均有导致'''致命性'''呼吸抑制的潜在危险性。
#服用劳拉西泮可能会导致生理和心理'''[[依赖性|依赖性]]'''。
#服用劳拉西泮时，可能会增加[[抑郁症|抑郁症]]患者[[自杀|自杀]]的可能性。因此，在患有[[抑郁症|抑郁症]]的患者服药时应密切观察并给予足够的[[抗抑郁药物|抗抑郁药物]]。
#服用本品不能驾驶汽车或操作重要机器。
#突然停药可能会导致[[戒断症状|戒断症状]]，长期治疗应逐渐减少药量而不是突然停药。
#有药物或酒精依赖倾向的患者用药时应密切监测，防止出现依赖性。

== 參考資料 ==
{{reflist}}

{{Anxiolytics}}
{{Template:止吐剂}}
{{精神药品品种目录}}

[[Category:止吐劑|Category:止吐劑]]
[[Category:苯二氮䓬类药物|Category:苯二氮䓬类药物]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]